Elon Musk, the founder of Neuralink, has revealed that the first human patient with a brain implant from his neurotechnology startup is now capable of moving a computer mouse solely with their thoughts.
Recently, Neuralink conducted an experimental brain implant procedure on its inaugural human patient, and Musk announced on Monday that the trial has been successful.
During an interview streamed on X, formerly known as Twitter, Musk mentioned that the patient has shown a complete recovery with no adverse effects. The individual is able to navigate the computer mouse on the screen through sheer thinking.
Musk expressed the company’s goal of maximizing button presses through mental commands, emphasizing the importance of having more options than just two buttons.
The technology developed by Neuralink utilizes a small device, approximately the size of five stacked coins, which is implanted into the human brain through a surgical procedure.
Established by Musk in 2016, Neuralink aims to establish direct communication links between the brain and computers. The ultimate objective is to enhance human capabilities significantly, address neurological disorders such as ALS and Parkinson’s disease, and potentially establish a symbiotic relationship between humans and artificial intelligence.
In the realm of brain-machine or brain-computer interface research, Musk faces competition from various entities working towards similar breakthroughs.
Encountering delays in his own project, Musk reportedly sought collaboration with implant developer Synchron. The Australia-based company successfully implanted its first device in a patient in the US in July 2022.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc.